{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:26:34Z","timestamp":1790655994802,"version":"4.1.0"},"reference-count":46,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Antimicrobial resistance of the E. coli O25 ST131 clonal lineage poses a significant therapeutic challenge worldwide, often involving resistance to fluoroquinolones and extended-spectrum beta-lactamase (ESBL) production. This retrospective study compared the dissemination of multidrug-resistant E. coli O25 ST131 isolated from the urine of outpatients at the largest Croatian clinical microbiology department across six years over two study periods. Methods: The E. coli O25 ST131 clonal lineage was detected via a rapid PCR method using pabB and trpA primers after positive agglutination with E. coli serogroup O25 antisera. ESBL phenotypes and antibiotic susceptibility were investigated according to EUCAST guidelines and breakpoint tables. Results: In the first period, there were a total of 45 isolates of E. coli O25 ST131, among which 30 were isolates with proven ESBL production. In the second period, a total of 114 isolates of E. coli O25 ST131 were detected, among which 75 (65.8%) were ESBL-positive (p &gt; 0.05). In ESBL-negative strains, the multidrug-resistant (MDR) phenotype was characterized by simultaneous resistance to ampicillin, co-trimoxazole, and fluoroquinolones (with an equal proportion of 3\/15 isolates in the first period and 7\/39 isolates in the second period, p &gt; 0.05). There was no statistically significant difference in the frequency of MDR detection across the two study periods (36\/45 and 98\/114, p &gt; 0.05). This is the first detection of E. coli O25 ST131 in the outpatient population in Zagreb. Conclusions: There was no statistically significant difference in the frequency of detecting the E. coli O25 ST 131 clone across the two study periods. The high frequency of MDR phenotype among ESBL-negative isolates of E. coli O25 ST131 and an equally high proportion of MDR strains among ESBL producers in this clonal lineage, with the total detection of MDR isolates \u2265 80% in both study periods, are the reasons why this bacterial clone poses a public health threat and why further investigation into its metabolic and virulence characteristics is needed in order to estimate its spreading potential among the outpatient population in Zagreb.<\/jats:p>","DOI":"10.3390\/antibiotics14020109","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T04:19:51Z","timestamp":1737433191000},"page":"109","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A First Report on Multidrug-Resistant Escherichia coli O25 ST131 Dissemination in an Outpatient Population in Zagreb, Croatia"],"prefix":"10.3390","volume":"14","author":[{"given":"Maja","family":"Anu\u0161i\u0107","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Dr. Andrija \u0160tampar Teaching Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Marijan","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Dr. Andrija \u0160tampar Teaching Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mlinari\u0107 D\u017eepina","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Dr. Andrija \u0160tampar Teaching Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimira","family":"Ti\u010di\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Dr. Andrija \u0160tampar Teaching Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucija","family":"Gr\u0161kovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3282-0973","authenticated-orcid":false,"given":"Jasmina","family":"Vrane\u0161","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Dr. Andrija \u0160tampar Teaching Institute of Public Health, 10000 Zagreb, Croatia"},{"name":"Department of Medical Microbiology and Parasitology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: A Pandemic, Multiresistant, Community-Associated Strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/AAC.05824-11","article-title":"Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) and blaCTX-M-15 among Extended-spectrum-\u03b2-Lactamase-Producing E. coli from the United States, 2000 to 2009","volume":"56","author":"Johnson","year":"2012","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/microorganisms3020236","article-title":"Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics","volume":"3","author":"Downing","year":"2015","journal-title":"Microorganisms"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Stoesser, N., Sheppard, A.E., Pankhurst, L., De Maio, N., Moore, C.E., Sebra, R., Turner, P., Anson, L.W., Kasarskis, A., and Batty, E.M. (2016). Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131. mBio, 7.","DOI":"10.1128\/mBio.02162-15"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00347-16","DOI":"10.1128\/mBio.00347-16","article-title":"Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131","volume":"7","author":"Ashcroft","year":"2016","journal-title":"mBio"},{"key":"ref_6","first-page":"273","article-title":"Intercontinental Emergence of Escherichia coli Clone O25:H4-ST131 Producing CTX-M-15","volume":"61","author":"Blanco","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/JCM.00640-08","article-title":"European Emergence of Ciprofloxacin-Resistant Escherichia coli Conal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis","volume":"46","author":"Cagnacci","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/JCM.02065-07","article-title":"Major Uropathogenic Escherichia coli Strain Isolated in the Northwest of England Identified by Multilocus Sequence Typing","volume":"46","author":"Lau","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/653932","article-title":"Escherichia coli Sequence Type ST131 as the Major Cause of Serious Multidrug-Resistant E. coli Infections in the United States","volume":"51","author":"Johnson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.01431-08","article-title":"BlaCTX-M genes in Escherichia coli Strains from Croatian Hospitals are Located in New (blaCTX-M-3a) and Widely Spread (blaCTX-M-3a and blaCTX-M-15) Genetic Structures","volume":"53","author":"Literacka","year":"2009","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/iju.14845","article-title":"Escherichia coli ST131 Isolated from Urological Patients Can Acquire Plasmid-Mediated Extended Spectrum \u03b2-Lactamase from Other Bacteria with High Frequency","volume":"29","author":"Kondo","year":"2022","journal-title":"Int. J. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12223-019-00769-1","article-title":"Extended-spectrum Beta Lactamases and Plasmid Diversity in Urinary Isolates of Escherichia coli in Croatia: A Nation-Wide, Multicentric, Retrospective Study","volume":"65","author":"Beader","year":"2020","journal-title":"Folia Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jmii.2015.08.005","article-title":"Virulence Factors, Antibiotic Resistance Phenotypes and O-serogroups of Escherichia coli Strains Isolated from Community-acquired Urinary Tract Infection Patients in Mexico","volume":"50","author":"Vaca","year":"2017","journal-title":"J Microbiol. Immunol. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Momtaz, H., Karimian, A., Madani, M., Safarpoor Dehkordi, F., Ranjbar, R., Sarshar, M., and Souod, N. (2013). Uropathogenic Escherichia coli in Iran: Serogroup Distributions, Virulence Factors and Antimicrobial Resistance Properties. Ann. Clin. Microbiol. Antimicrob., 12.","DOI":"10.1186\/1476-0711-12-8"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jac\/dkp194","article-title":"Rapid Detection of the O25b-ST131 Clone of Escherichia coli Encompassing the CTX-M-15-Producing Strains","volume":"64","author":"Clermont","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e1236","DOI":"10.1093\/cid\/ciac421","article-title":"Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies","volume":"76","author":"Weerdenburg","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","unstructured":"The Croatian Academy of Medical Sciences (CAMS) (2012). Antibiotic Resistance in Croatia, 2011, CAMS."},{"key":"ref_18","unstructured":"The Croatian Academy of Medical Sciences (2013). Antibiotic Resistance in Croatia, 2012, CAMS."},{"key":"ref_19","unstructured":"The Croatian Academy of Medical Sciences (2018). Antibiotic Resistance in Croatia, 2017, CAMS."},{"key":"ref_20","unstructured":"The Croatian Academy of Medical Sciences (2019). Antibiotic Resistance in Croatia, 2018, CAMS."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jac\/dkr451","article-title":"Population Structure, Virulence Potential and Antibiotic Susceptibility of Uropathogenic Escherichia coli from Northwest England","volume":"67","author":"Gibreel","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/jac\/dkr349","article-title":"Molecular Epidemiology of Extraintestinal Pathogenic Escherichia coli Isolates from a Regional Cohort of Elderly Patients Highlights the Prevalence of ST131 Strains with Increased Antimicrobial Resistance in Both Community and Hospital Care Settings","volume":"66","author":"Croxall","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/jac\/dkp122","article-title":"Molecular Epidemiology of Escherichia coli Producing Extended-Spectrum Beta-Lactamases in Lugo (Spain): Dissemination of Clone O25b:H4-ST131 Producing CTX-M-15","volume":"63","author":"Blanco","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/dkt405","article-title":"Escherichia coli Belonging to the Worldwide Emerging Epidemic Clonal Group O25b\/ST131: Risk Factors and Clinical Implications","volume":"69","author":"Navarro","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/1469-0691.12413","article-title":"Epidemiology of Extended-spectrum \u03b2-lactamase-producing Escherichia coli in Sweden 2007\u20132011","volume":"20","author":"Brolund","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.1038\/s41598-022-14177-y","article-title":"The Impact of the ST131 Clone on Recurrent ESBL-Producing E. coli Urinary Tract Infection: A Prospective Comparative Study","volume":"12","author":"Lindblom","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/AAC.00297-09","article-title":"Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-resistant Urinary Tract Infections in Canada, 2002 to 2004","volume":"53","author":"Johnson","year":"2009","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/671725","article-title":"Predictors and Molecular Epidemiology of Community-Onset Extended-spectrum \u03b2-lactamase-producing Escherichia coli Infection in a Midwestern Community","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1128\/AAC.01065-13","article-title":"The Clonal Distribution and Diversity of Extraintestinal Escherichia coli Isolates vary According to Patient Characteristics","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/jac\/dkq236","article-title":"Clonal Group Distribution of Fluoroquinolone-resistant Escherichia coli among Humans and Companion Animals in Australia","volume":"65","author":"Platell","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_31","first-page":"840","article-title":"Drug Resistance, Serotypes, and Phylogenetic Groups among Uropathogenic Escherichia coli including O25-ST131 in Mexico City","volume":"15","year":"2011","journal-title":"J Infect. Dev. Ctries."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/669865","article-title":"Escherichia coli Sequence Type 131 is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cherubini, S., Perilli, M., Azzini, A.M., Tacconelli, E., Maccacaro, L., Bazaj, A., Naso, L., Amicosante, G., Ltcf-Veneto Working Group, and Lo Cascio, G. (2022). Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region. Diagnostics, 12.","DOI":"10.3390\/diagnostics12010213"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Shahbazi, R., Salmanzadeh-Ahrabi, S., Aslani, M.M., Alebouyeh, M., Falahi, J., and Nikbin, V.S. (2023). The Genotypic and Phenotypic Characteristics Contributing to High Virulence and Antibiotics Resistance in Escherichia coli O25-B2-ST131 in Comparison to non- O25-B2-ST131. BMC Pediatr., 23.","DOI":"10.1186\/s12887-023-03866-w"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.01604-13","article-title":"Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones Among Extended-Spectrum-\u03b2-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1128\/JCM.00919-12","article-title":"Phylogenetic Distribution of CTX-M- and Non-Extended-Spectrum-\u03b2-Lactamase-Producing Escherichia coli Isolates: Group B2 Isolates, Except Clone ST131, Rarely Produce CTX-M enzymes","volume":"50","author":"Brisse","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1128\/AAC.03679-14","article-title":"Temporal Trends in Antimicrobial Resistance and Virulence-associated Traits within the Escherichia coli Sequence Type 131 Clonal Group and Its H30 and H30-Rx Subclones, 1968 to 2012","volume":"58","author":"Olesen","year":"2014","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/JCM.00346-13","article-title":"Prevalence and Characteristics of the Epidemic Multiresistant Escherichia coli ST131 Clonal Group among Extended-Spectrum Beta-Lactamase-Producing E. coli Isolates in Copenhagen, Denmark","volume":"51","author":"Olesen","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1128\/AAC.02428-14","article-title":"Characteristics of Escherichia coli Sequence Type 131 Isolates that Produce Extended-Spectrum \u03b2-Lactamases: Global Distribution of the H30-Rx Sublineage","volume":"58","author":"Peirano","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e00912-17","DOI":"10.1128\/AAC.00912-17","article-title":"Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131- H 30Rx and ST131- H 30R1 Strains","volume":"61","author":"Kanamori","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1128\/JCM.01315-13","article-title":"Escherichia coli Sequence Type 131 as a Prominent Cause of Antibiotic Resistance among Urinary Escherichia coli Isolates from Reproductive-Age Women","volume":"51","author":"Kudinha","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_42","first-page":"294","article-title":"Distribution of Ciprofloxacin-Resistance Genes among ST131 and non-ST131 Clones of Escherichia coli Isolates with ESBL Phenotypes Isolated from Women with Urinary Tract Infection","volume":"13","author":"Rasoulinasab","year":"2021","journal-title":"Iran J. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/cid\/ciy523","article-title":"The Uropathogenic Escherichia coli Subclone Sequence Type 131-H30 Is Responsible for Most Antibiotic Prescription Errors at an Urgent Care Clinic","volume":"15","author":"Tchesnokova","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2009.11.003","article-title":"Molecular Epidemiology of Escherichia coli Producing CTX-M Beta-Lactamases: The Worldwide Emergence of Clone ST131 O25:H4","volume":"35","author":"Peirano","year":"2010","journal-title":"Int. J. Antimicrob. Agents."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/AAC.00119-14","article-title":"Fluoroquinolone-resistant Escherichia coli Sequence Type 131 Isolates Causing Bloodstream Infections in a Canadian Region with a Centralized Laboratory System: Rapid Emergence of the H30-Rx Sublineage","volume":"58","author":"Peirano","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","unstructured":"(2025, January 20). The EUCAST Guideline on Detection of Resistance Mechanisms v 2.0 (2017-07-11) 2019. Available online: http:\/\/www.eucast.org\/resistance_mechanisms\/."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/2\/109\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:32:41Z","timestamp":1759919561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/2\/109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["antibiotics14020109"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14020109","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}